Gary W Ashley

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Emergency Department

Oxidative Stress

Top Venues

Cancer research communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shaun D Fontaine, Christopher W Carreras, Ralph R Reid, Gary W Ashley, Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors. Cancer research communications 3 (5) (2023)
Shaun D Fontaine, Christopher W Carreras, Ralph R Reid, Gary W Ashley, Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors. Cancer research communications 3 (5) (2023)
Shaun D Fontaine, Christopher W Carreras, Ralph R Reid, Gary W Ashley, Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors. Cancer research communications 3 (5) (2023)
Shaun D Fontaine, Christopher W Carreras, Ralph R Reid, Gary W Ashley, Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors. Cancer research communications 3 (5) (2023)
Shaun D Fontaine, Christopher W Carreras, Ralph R Reid, Gary W Ashley, Daniel V Santi
A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors. Cancer research communications 3 (5) (2023)
Anish Thomas, Shaun D Fontaine, Morgan E Diolati, Parth Desai, Rajesh Kumar, Nobuyuki Takahashi, Linda Sciuto, Samantha Nichols, Alan Ashworth, Felix Y Feng, Gary W Ashley, Minh Nguyen, Yves Pommier, Daniel V Santi
PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP Inhibitors. Molecular cancer therapeutics 21 (11) (2022)